13:00-13:06 | Speech |
Speech |
|
||||||||||||||||
13:06-13:25 | Discuss |
High-quality Management of Day Surgery Anesthesiology Experts Discussion |
|
||||||||||||||||
13:25-13:30 | Summary |
Summary |
|
13:30-13:55 | Featured Presentation |
Ketamine Enantiomers: Bridging Anesthesia and Antidepressant Therapy |
|
||||
13:55-14:20 | Featured Presentation |
Practice and research of chronic pain in the field of regenerative medicine |
|
||||
14:20-14:45 | Featured Presentation |
Progress in postoperative analgesia |
|
||||
14:45-15:10 | Featured Presentation |
Accessing the power of the mind: Dissecting the neural basis of placebo analgesia |
|
15:10-15:35 | Featured Presentation |
Clinical Practice Guidelines for Postoperative Pain Management in Adults |
|
||||
15:35-16:00 | Featured Presentation |
The neural network mechanisms of chronic pain and related emotional disorders |
|
||||
16:00-16:25 | Featured Presentation |
Neuromodulation in Cancer Pain Management |
|
||||
16:25-16:50 | Featured Presentation |
New Ideas for Perioperative Pain Management |
|
||||
16:50-17:00 | Oral Presentation |
Evaluating the Opioid-Related Adverse Events of Oliceridine Versus Conventional Opioids in Patient-Controlled Analgesia After Thoracoscopic Lung Resection: A Retrospective Cohort Study |
|
17:00-17:05 | Speech |
Speech |
|
||||||||||||||||||||||||||||||||||||
17:05-17:15 | Comment |
Panel Discussion:《Expert Consensus on Clinical Practice of Oxycodone Hydrochloride Injection》 |
|
||||||||||||||||||||||||||||||||||||
17:15-17:25 | Symposium |
Introduction to the Development of Expert Consensus on Clinical Practice of Oxycodone Hydrochloride Injection |
|
||||||||||||||||||||||||||||||||||||
17:25-17:45 | Symposium |
Interpretation: 《Expert Consensus on Clinical Practice of Oxycodone Hydrochloride Injection》 |
|
||||||||||||||||||||||||||||||||||||
17:45-18:00 | Discuss |
Meeting Discussions 1 |
|
||||||||||||||||||||||||||||||||||||
18:00-18:15 | Discuss |
Meeting Discussions 2 |
|
||||||||||||||||||||||||||||||||||||
18:15-18:20 | Summary |
Summary |
|